Literature DB >> 31897433

THYMIC CARCINOID WITH ADRENOCORTICOTROPIC HORMONE-PRODUCING ECTOPIC CUSHING SYNDROME AND EMPTY SELLA.

Artak Labadzhyan1, Se-Min Kim1, Jane Rhyu1, Takako Araki2, Ali Mahtabifard3, Shlomo Melmed1.   

Abstract

OBJECTIVE: Ectopic Cushing's syndrome secondary to thymic carcinoid is a rare disorder that may be difficult to diagnose and manage.
METHODS: We describe a case of severe Cushing's syndrome secondary to a large adrenocorticotropic hormone (ACTH) producing thymic carcinoid in a patient with history of primary hyperaldosteronism.
RESULTS: A 43-year-old female with a 20-year history of an aldosterone-secreting adrenocortical adenoma status post right adrenalectomy presented with acute onset of proximal muscle weakness, swelling, facial hirsutism, and severe hypokalemia. Ectopic Cushing's Syndrome was suspected based on the sudden symptom onset and markedly elevated 24-hr urine cortisol and ACTH levels. MRI revealed an empty pituitary sella and a large (7.3 cm) mediastinal mass visible on chest CT. The mass was resected by video-assisted thoracoscopic surgery, resulting in resolution of symptoms and cortisol levels. Pathology assessment confirmed well-differentiated thymic carcinoid with positive ACTH staining.
CONCLUSION: The case highlights clinical features, challenges in diagnostic work up, treatment modalities, and associated endocrine findings in a thymic carcinoid abutting the heart and presenting with ectopic ACTH secretion.

Entities:  

Keywords:  ACTH; EAS; Thymic carcinoid; ectopic Cushing’s syndrome; empty sella; hyperaldosteronism; neuroendocrine carcinoma of thymus

Year:  2018        PMID: 31897433      PMCID: PMC6939296          DOI: 10.4158/ACCR-2018-0045

Source DB:  PubMed          Journal:  AACE Clin Case Rep        ISSN: 2376-0605


  17 in total

1.  The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up.

Authors:  Andrea M Isidori; Gregory A Kaltsas; Carlotta Pozza; Vanni Frajese; John Newell-Price; Rodney H Reznek; Paul J Jenkins; John P Monson; Ashley B Grossman; G Michael Besser
Journal:  J Clin Endocrinol Metab       Date:  2005-11-22       Impact factor: 5.958

2.  Thymic neuroendocrine tumors: a SEER database analysis of 160 patients.

Authors:  Puja Gaur; Colleen Leary; James C Yao
Journal:  Ann Surg       Date:  2010-06       Impact factor: 12.969

3.  Neuroendocrine tumors, version 1.2015.

Authors:  Matthew H Kulke; Manisha H Shah; Al B Benson; Emily Bergsland; Jordan D Berlin; Lawrence S Blaszkowsky; Lyska Emerson; Paul F Engstrom; Paul Fanta; Thomas Giordano; Whitney S Goldner; Thorvardur R Halfdanarson; Martin J Heslin; Fouad Kandeel; Pamela L Kunz; Boris W Kuvshinoff; Christopher Lieu; Jeffrey F Moley; Gitonga Munene; Venu G Pillarisetty; Leonard Saltz; Julie Ann Sosa; Jonathan R Strosberg; Jean-Nicolas Vauthey; Christopher Wolfgang; James C Yao; Jennifer Burns; Deborah Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2015-01       Impact factor: 11.908

4.  Ectopic ACTH syndrome: our experience with 25 cases.

Authors:  Luiz Roberto Salgado; Maria Candida B Villares Fragoso; Mirta Knoepfelmacher; Marcio Carlos Machado; Sorahia Domenice; Maria Adelaide Albergaria Pereira; Berenice Bilharinho de Mendonça
Journal:  Eur J Endocrinol       Date:  2006-11       Impact factor: 6.664

5.  Rapid control of severe neoplastic hypercortisolism with metyrapone and ketoconazole.

Authors:  Jean-Benoît Corcuff; Jacques Young; Pauline Masquefa-Giraud; Philippe Chanson; Eric Baudin; Antoine Tabarin
Journal:  Eur J Endocrinol       Date:  2015-01-26       Impact factor: 6.664

6.  Long-term outcome for early stage thymoma: comparison between thoracoscopic and open approaches.

Authors:  Pio Maniscalco; Nicola Tamburini; Francesco Quarantotto; William Grossi; Elena Garelli; Giorgio Cavallesco
Journal:  Thorac Cardiovasc Surg       Date:  2015-01-28       Impact factor: 1.827

7.  EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas.

Authors:  Hidenori Fukuoka; Odelia Cooper; Anat Ben-Shlomo; Adam Mamelak; Song-Guang Ren; Dave Bruyette; Shlomo Melmed
Journal:  J Clin Invest       Date:  2011-11-21       Impact factor: 14.808

8.  Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease.

Authors:  Ning-Ai Liu; Takako Araki; Daniel Cuevas-Ramos; Jiang Hong; Anat Ben-Shlomo; Yukiko Tone; Masahide Tone; Shlomo Melmed
Journal:  J Clin Endocrinol Metab       Date:  2015-05-05       Impact factor: 5.958

9.  Cushing syndrome due to ectopic adrenocorticotropic hormone secretion.

Authors:  J P Aniszewski; W F Young; G B Thompson; C S Grant; J A van Heerden
Journal:  World J Surg       Date:  2001-07       Impact factor: 3.352

10.  Comparative assessment of ACTH and lipotropin plasma levels in the diagnosis and follow-up of patients with Cushing's syndrome: a study of 210 cases.

Authors:  J M Kuhn; M F Proeschel; D J Seurin; X Y Bertagna; J P Luton; F L Girard
Journal:  Am J Med       Date:  1989-06       Impact factor: 4.965

View more
  1 in total

Review 1.  Ectopic Cushing's syndrome due to thymic neuroendocrine tumours: a systematic review.

Authors:  Fernando Guerrero-Pérez; Inmaculada Peiró; Agustina Pia Marengo; Alex Teulé; José Carlos Ruffinelli; Roger Llatjos; Teresa Serrano; Ivan Macia; Nuria Vilarrasa; Pedro Iglesias; Carles Villabona
Journal:  Rev Endocr Metab Disord       Date:  2021-05-07       Impact factor: 6.514

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.